Researchers at a UK university are investigating a potential link between endometriosis and cancer risk, focusing on a condition that affects roughly one in 10 women in the country. Endometriosis occurs when tissue similar to the uterine lining grows outside the womb, causing severe pain, heavy bleeding, and fertility problems for millions of women globally.
The study examines whether women with endometriosis face elevated risks for certain cancer types, particularly ovarian cancer. Scientists are analyzing biological mechanisms that might explain any connection between the two conditions, including chronic inflammation, abnormal cell growth patterns, and shared genetic factors. Early research suggests women with endometriosis may have a modestly increased risk of developing ovarian and breast cancers, though absolute risk remains relatively low.
This investigation matters because endometriosis diagnosis often takes years, with many women experiencing a diagnostic delay of seven to 12 years. The condition disrupts quality of life through debilitating pelvic pain, painful intercourse, and reduced fertility. Currently, treatment options include pain management, hormonal therapies, and surgery, but there is no cure.
Understanding the endometriosis-cancer relationship could reshape how doctors screen and monitor affected women. If confirmed, findings might lead to earlier detection protocols or preventative strategies for high-risk patients. The research also highlights how endometriosis remains underfunded relative to its prevalence, despite affecting roughly 190 million women worldwide.
The university's work joins growing international efforts to unpack endometriosis biology and improve patient outcomes. Better understanding of potential cancer links could accelerate development of targeted therapies and inform long-term health management strategies for the millions of women living with this chronic condition.